Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract

Cancer

Volumn 85, Issue 9, 1999, Pages 1903-1909

  Pintos, Javier ^a   Franco, Eduardo L ^a,d   Black, Martin J ^b   Bergeron, Jean ^c   Arella, Maximilien ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Human papillomavirus; Prognosis; Survival; Upper aerodigestive tract neoplasms

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; LARYNX TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHARYNX TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT CANCER; UPPER GASTROINTESTINAL TRACT; UPPER RESPIRATORY TRACT; VIRUS DETECTION; WART VIRUS;

EID: 0033134906     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6     Document Type: Article

References (44)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen majors cancers in 1985. Int J Cancer 1993;54:594-606.
2. Blot WJ, Devesa SS, McLaughlin JK, Fraumeni JF Jr. Oral and pharyngeal cancers. Cancer Surv 1994;19-20:23-42.
3. Rothman KJ, Cann CI, Flanders W, Fried MP. Epidemiology of laryngeal cancer. Epidemiol Rev 1980;2:195-209.
4. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.
5. Franco EL, Kowalski LP, Oliveira BV, Curado MP, Pereira RN, Silva ME, et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer 1989;43:992-1000.
6. Graham S, Mettlin C, Marshall J, Priore R, Rzepka T, Shedd D. Dietary factors in the epidemiology of cancer of the larynx. Am J Epidemiol 1981;113:675-80.
7. McLaughlin JK, Gridley G, Block G, Winn DM, Preston-Martin S, Schoenberg JB, et al. Dietary factors in oral and pharyngeal cancer. J Nat Cancer Inst 1988;80:1237-43.
8. Franceschi S, Bidoli E, Barón AE, Barra S, Talamini R, Serraino D, et al. Nutrition and cancer of the oral cavity and pharynx in northeast Italy. Int J Cancer 1991;47:20-5.
9. IARC monographs on the evaluation of carcinogenic risks of chemicals to humans. Volume 64. Human papillomaviruses. Lyon: IARC, 1995.
10. Franceschi S, Muñoz N, Bosch XF, Snijders PJ, Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996;5:567-75.
11. Pérez-Ayala M, Ruiz-Cabello F, Esteban F, Concha A, Redondo M, Oliva MR, et al. Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 1990;46:8-11.
12. Hoshikawa T, Nakajima T, Uhara H, Gotoh M, Shimosato Y, Tsutsumi K, et al. Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction. Laryngoscope 1990;100:647-50.
13. Brandwein MS, Nuovo GJ, Biller H. Analysis of prevalence of human papillomavirus in laryngeal carcinomas: study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 1993;102:309-13.
14. Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C, Kittas C. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch 1994;425:481-9.
15. Suzuki T, Shidara K, Hara F, Nakajima T. High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection. Jpn J Cancer Res 1994;85:1087-93.
16. Salam MA, Rockett J, Morris A. General primer-mediated polymerase chain reaction for simultaneous detection and typing of human papillomavirus DNA in laryngeal squamous cell carcinomas. Clin Otolaryngol 1995;20:80-4.
17. Kasperbauer JL, O'Halloran GL, Espy MJ, Smith TF, Lewis JE. Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinoma of the larynx. Laryngoscope 1993;103:416-20.
18. Fliss DM, Noble-Topham SE, McLachlin CM, Freeman JL, Noyek AM, vanNostrand AWP, et al. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope 1994;104:146-52.
19. Franco EL Prognostic value of human papillomavirus in the survival of cancer patients: an overview of the evidence. Cancer Epidemiol Biomarkers Prev 1992;1:499-504.
20. Riou G, Favre M, Jeannel D, Bourhis J, Ledoussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990;335:1171-4.
21. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;338:910-3.
22. DeBritton RC, Hildesheim A, Delao SL, Brinton LA, Sathya P, Reeves WC. Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol 1993;81:19-24.
23. Ikenberg H, Sauerbrei W, Schottmuller U, Spitz C, Pfleiderer A. Human papillomavirus DNA in cervical carcinoma: correlation with clinical data and influence on prognosis. Int J Cancer 1994;59:322-6.
24. Franco EL, Bergeron I, Villa L, Arella M, Richardson L, Arseneau J, et al. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study. Cancer Epidemiol Biomarkers Prev 1996;5:271-5.
25. Hermanek P, Sobin LH. TNM classification of malignant tumours. Berlin: Spinger-Verlag, 1987.
26. Shibata DK, Arnheim N, Martin WJ. Detection of human papillomavirus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 1988;167:225-30.
27. Bauer H, Greer C, Manos MM. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington CS, McGee JOD, editors. Diagnostic molecular pathology: a practical approach. Oxford: IRL Press, 1992:131-52.
28. Sambrook J, Fritsh EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd Edition. Cold Spring Harbour Laboratory, 1989.
29. Snijders PJF, van den Brule AJC, Schrijnemakers HFJ, Snow G, Meijer CJLM, Walboomers JMM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomaviruses genotypes. J Gen Virol 1990;71:173-81.
30. de Roda-Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
31. Walboomers JMM, Melkert PWJ, van den Brule AJC, Snijders PJF, Meijer JLM. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In: Herrington CS, McGee JOD, editors. Diagnostic molecular pathology: a practical approach. Oxford: IRL Press, 1992:153-72.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
33. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
34. Campos-Filho N, Franco EL Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Comput Methods Program Biomed 1988;27: 223-8.
35. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:187-220.
36. Campos-Filho N, Franco EL. Microcomputer-assisted multivariate survival data analysis using Cox's proportional hazards regression model. Comput Methods Program Biomed 1990;31:81-7.
37. Steinberg BM, DiLorenzo TP. A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 1996;15:91-112.
38. Brandwein M, Zeitlin J, Nuovo GJ, MacConnell P, Bodian C, Urken M, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994;7:720-7.
39. Clayman GL, Stewart MG, Weber RS, El-Naggar AK, Grimm EA. Human papillomavirus in laryngeal and hypopharyngeal carcinomas: relationship to survival. Arch Otolaryngol Head Neck Surg 1994;120:743-8.
40. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996;12: 1663-8.
41. Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2:755-62.
42. Riethdorf S, Friedrich RE, Ostwald C, Barten M, Gogacz P, Gundlach KK, et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997;26:315-21.
43. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996;66:464-9.
44. Sugerman PB, Shillitoe EJ. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis 1997;3:130-47.